Transcript
Page 1: Specialist Palliative Care in ESLD: An Introduction

SPECIALIST PALLIATIVE CARE IN

ESLD:AN INTRODUCTION

KYLE P. EDMONDS, MD

ASSISTANT CLINICAL PROFESSOR

HOWELL PALLIATIVE CARE SERVICE

UCSD HEALTH SCIENCES

Page 2: Specialist Palliative Care in ESLD: An Introduction

OBJECTIVES

• UNDERSTAND THE ROLE OF PALLIATIVE CARE IN SERIOUS ILLNESS

• AWARENESS OF THE CONCEPTS OF GENERALIST VS. SPECIALIST PALLIATIVE CARE

• NAME THE PREFERRED ADJUVANT PAIN MEDICATION IN ESLD

• DESCRIBE THE DIFFERENTIAL OF ABERRANT DRUG-TAKING BEHAVIOR & A STRATEGY TO SAFELY PRESCRIBE CONTROLLED SUBSTANCES

• EXPLAIN HOW THE CONCEPT OF TIME-LIMITED TRIALS RELATES TO GOALS OF CARE

Page 3: Specialist Palliative Care in ESLD: An Introduction

YOUR CHALLENGES IN INVOLVING PALLIATIVE CARE?

Page 4: Specialist Palliative Care in ESLD: An Introduction

THE COMMON ANSWER

Time

Palliative

Care

Routine Medical Care:antibiotics, dialysis, chemotherapy, surgery

“Dying”?

“Nothing more to do”?

“Pt / family request”?

“Really sick”?

“Really, really sick”?

Page 5: Specialist Palliative Care in ESLD: An Introduction

PROGNOSIS: MOVING TARGET

RAND, 2005.

Page 6: Specialist Palliative Care in ESLD: An Introduction

PALLIATIVE CARE AS EXPERT PARTNER

AVAILABLE AT ANY AGE AND AT ANY STAGE IN A SERIOUS ILLNESS AND

CAN BE PROVIDED ALONG WITH CURATIVE TREATMENT.

Page 7: Specialist Palliative Care in ESLD: An Introduction

Time

General / Specialty Palliative

Care

Routine Medical Care

The Course of Illness

Page 8: Specialist Palliative Care in ESLD: An Introduction

Gastroenterology

Generalist Palliative

CareSpecialist Palliative

Care

•MOA•TACE•Antibiotics

•ondansetron•opioids

•Complex pain•High dose opioids•Limit setting•Hope & Prognostication

Page 9: Specialist Palliative Care in ESLD: An Introduction

A.R. CASE

• 67 YEAR OLD MALE

• ETOH & HEP C CIRRHOSIS

• JANUARY DX’ED WITH HCC

• SYMPTOMS: FATIGUE AND CHRONIC BACK PAIN ON HIGH DOSE OPIOIDS

• APRIL: TACE

• SYMPTOMS: “SEVERE” PAIN, NAUSEA AND CONSTIPATION

• MAY

• ADMITTED “SEVERE” ABDOMINAL PAIN

• REQUESTING SPECIFIC MEDS AND DOSES

Page 10: Specialist Palliative Care in ESLD: An Introduction

A.R. CASE

• OVERNIGHT: DECOMPENSATED

• “SEVERE” ABDOMINAL PAIN, “HARD TIME BREATHING”

• TRANSFERRED TO ICU

• PALLIATIVE CARE CALLED

• PATIENT DNAR/FULL CARE

• SEVERE PAIN AND DYSPNEA

• PATIENT DIED NEXT MORNING IN THE ICU

• DPOA: “HE TOLD ME HE WANTED TO DIE AT HOME.”

Page 11: Specialist Palliative Care in ESLD: An Introduction

HOW COULD WE HAVE HELPED EARLIER?

• EXPERT PAIN MANAGEMENT

• ACUTE ON CHRONIC PAIN

• EVALUATING ABERRANT DRUG-TAKING BEHAVIOR

• PAIN CONTROL W/ HX OF SUBSTANCE ABUSE

• “TOTAL PAIN” ASSESSMENT

• COPING ASSESSMENT / INTERVENTION

• SEVERE DISEASE

• HISTORICAL ALCOHOLISM

• EARLY GOALS OF CARE

• RAPPORT BUILDING

Page 12: Specialist Palliative Care in ESLD: An Introduction

PALLIATIVE CARE AS EXPERT PARTNER

A TEAM THAT CAN HELP YOUR PATIENTS AND FAMILIES MANAGE THE PAIN, SYMPTOMS,

AND STRESS OF SERIOUS ILLNESS.

Page 13: Specialist Palliative Care in ESLD: An Introduction

CLASSIFICATION OF PAIN

• PHYSIOLOGIC

• NOCICEPTIVE

• NEUROPATHIC

• MIXED

• TEMPORAL

• ACUTE

• CHRONIC

Page 14: Specialist Palliative Care in ESLD: An Introduction

WHO LADDER ELEVATOR

1, Pain 1 – 3

2, Pain 4 – 6

3, Pain 7 – 10

Morphine

Hydromorphone

Fentanyl

OxycodoneMethadone

± Adjuvants

Tramadol

A / Hydrocodone

A / Oxycodone

± AdjuvantsAcetaminophen

NSAID’s

± Adjuvants

WHO. Geneva, 1996.

Page 15: Specialist Palliative Care in ESLD: An Introduction

EXPERT PAIN MGMT

General Principles

(Maximize non-pharm / non-opioid adjuvants)

Initiate at low doses

Dose by pharmacologic principles

Long-acting formulations avoided as much as possible

Monitor decompensated patient for side effects

Kirsch & Passik, 2006.

Page 16: Specialist Palliative Care in ESLD: An Introduction

FAVORED ADJUVANT

Gabapentin:

Visceral pain, sleep, anxiolysis

Minimal hepatic metabolism

Minimal protein binding

Renal excretion

Dwyler et al., 2014.

Page 17: Specialist Palliative Care in ESLD: An Introduction

OPIOIDS

Morphine Oxycodone Tramadol

Inc half-life & bioavailability; dec clearance

Elimination is severely impaired

CYP2D6 metabolism to

active M1 form??

22

Grond & Seblotzki 2004.

Page 18: Specialist Palliative Care in ESLD: An Introduction

OPIOIDS

Consider:

Fentanyl

Short-acting morphine

Page 19: Specialist Palliative Care in ESLD: An Introduction

19

“TOTAL PAIN”

Pain

Disease Mgmt

Physical

Psych

SocialSpiritual

Practical

EOL Worry

Page 20: Specialist Palliative Care in ESLD: An Introduction

20

DX: ABERRANT DRUG-TAKING BEHAVIOR

• DESPERATION OVER SXS

• AGGRESSIVELY COMPLAINING

• REQUESTING SPECIFIC DRUG

• BUYING OPIOIDS ON STREET

• DOCTOR SHOPPING

• PRESCRIPTION FORGERY

Passik et al. JClinPain. 2006.

Page 21: Specialist Palliative Care in ESLD: An Introduction

DDX: ABERRANT DRUG TAKING BEHAVIOR

• TOLERANCE• PSEUDO-

ADDICTION• DRUG DIVERSION• ADDICTION

Page 22: Specialist Palliative Care in ESLD: An Introduction

PSYCHOSOCIAL CONSIDERATIONS

Alcohol or Substance Abuse

Hx “chemical coping”

Perceiving judgment / blame

Alexithymia (not “in tune”)• Symptom assessment challenging• Need alternative ways to assess

5

Page 23: Specialist Palliative Care in ESLD: An Introduction

PALLIATION IN HISTORICAL SUBSTANCE ABUSE

Limit-setting

Use adjuvant medications whenever possible

Use non-drug adjuvants (relaxation, distraction, biofeedback)

Clinic risk stratification / procedures

Multidisciplinary assessments

Involve addiction specialists

34

Passik et al. 2006.

Page 24: Specialist Palliative Care in ESLD: An Introduction

OPIOID RISK TOOL FOR SCREENING

• STRATIFY PATIENT OPIOID ABUSE RISK BASED UPON

• FAMILY HX OF SUBSTANCE ABUSE

• PERSONAL HX OF SUBSTANCE ABUSE

• AGE

• SEX

• HX OF PREADOLESCENT SEXUAL ABUSE

• PSYCH D/O

Chou et al. JClinPain. 2009.

Page 25: Specialist Palliative Care in ESLD: An Introduction

HISTORICAL SUBSTANCE ABUSE

• MEANS OF COPING W/ STRESS

• MORE LIKELY TO RETURN W/ STRESS

• IMPACTS ADHERENCE TO RX REGIMENS

Page 26: Specialist Palliative Care in ESLD: An Introduction

PALLIATIVE CARE AS PARTNER

EXPERT COMMUNICATION FOR CHALLENGING SITUATIONS.

Page 27: Specialist Palliative Care in ESLD: An Introduction

GOALS OF CARE COMMUNICATION

• NORMALIZE DISCUSSION

• “HOPE FOR THE BEST & PLAN FOR THE WORST”

• PROGNOSTICATION NOT ASSOCIATED W/ LOSS OF HOPE

• COMMON PITFALL: ASSUMING HOPE ONLY = CURE

Page 28: Specialist Palliative Care in ESLD: An Introduction

“GOALS OF CARE” ≠ CODE STATUS

Goals of

Care

Hopes

Fears

Values

Code Statu

s

Patient/Family Us

Page 29: Specialist Palliative Care in ESLD: An Introduction

GOALS OF CARE

PERCEPTION OF CURRENT HEALTH

EXPLORE LIFE BEFORE PRESENT ILLNESS

RELATE PAST AND PRESENT

SOURCES OF WORRY OR CONCERN

OUTLINE THE PLAN

NOTIFY IMPORTANT PEOPLE

Page 30: Specialist Palliative Care in ESLD: An Introduction

POTENTIAL GOALS OF CARE

Restorative or Cure

Return to Baseline

Improve Survival

Improve Function

Relieve Symptoms

Allow Natural Death

Adapted from Mulkerin, 2011.

Page 31: Specialist Palliative Care in ESLD: An Introduction

TIME-LIMITED TRIALS

• AGREE EARLY WITH INTERESTED PARTIES ON:• EXACT LENGTH OF

TIME

• SPECIFIC GOALS

• WHAT WILL HAPPEN IF GOALS NOT MET

Page 32: Specialist Palliative Care in ESLD: An Introduction

PALLIATIVE CARE AS PARTNER

PARTNERING WITH YOU FOR BETTER OUTCOMES BY HELPING YOUR PATIENTS TOLERATE CURATIVE TREATMENT.

Page 33: Specialist Palliative Care in ESLD: An Introduction

A.L. CASE & QUESTIONS

• 65YOM W/ ETOH / HCV ESLD LISTED FOR TX

• HX OF IVDA AND METHADONE MAINTENANCE

• A/W AMS D/T HYPONA AND HEPATIC ENCEPHALOPATHY

• PAIN OUT OF CONTROL, THREATENING TO LEAVE AMA D/T OPIOID LIMITATIONS = “ADDICTION”?

• 6MG OF IV DILAUDID IN 24 HOURS (120MG OME)

• TEARFUL, ANGRY = “DEPRESSED”?

Page 34: Specialist Palliative Care in ESLD: An Introduction

A.L. PALLIATIVE ASSESSMENT• COMPLEX PAIN

• NO ABERRANT DRUG-TAKING BEHAVIOR

• NOT DEPRESSED

• GRIEVING: “ACUTE GRIEF OVER LOSS OF FUNCTION”

• UNCERTAINTY: “WONDERING HOW HIS LIFE WILL UNFOLD”

• COPES THROUGH SPIRITUALITY & INTERACTION W/ PEOPLE

• GOALS

• PAIN CONTROLLED

• TRANSPLANT

• HOME

Page 35: Specialist Palliative Care in ESLD: An Introduction

A.L. PALLIATIVE RECOMMENDATIONS

• CHANGE HYDROMORPHONE TO PO

• GABAPENTIN 300MG AT HS (SLEEP, PAIN, ANXIETY)

• EXPLORED GUIDED IMAGERY & JOURNALING

• ENCOURAGED NURSING TO MAKE FREQUENT VISITS

Page 36: Specialist Palliative Care in ESLD: An Introduction

A.L. OUTCOME

• DECREASED OPIOID NEED

• DECREASED ANGER & INCREASED PARTICIPATION IN CARE

• TRANSPLANT

• HOME ON ORAL MEDS W/ PLAN TO WEAN

Page 37: Specialist Palliative Care in ESLD: An Introduction

PALLIATIVE CARE

• A TEAM THAT CAN HELP YOUR PATIENTS AND FAMILIES MANAGE THE PAIN, SYMPTOMS, AND STRESS OF SERIOUS ILLNESS.

• AVAILABLE AT ANY AGE AND AT ANY STAGE IN A SERIOUS ILLNESS AND CAN BE PROVIDED ALONG WITH CURATIVE TREATMENT.

• EXPERT COMMUNICATION FOR CHALLENGING SITUATIONS.

• PARTNERING WITH YOU FOR BETTER OUTCOMES BY HELPING YOUR PATIENTS TOLERATE CURATIVE TREATMENT.

Page 38: Specialist Palliative Care in ESLD: An Introduction

SPECIALIST PALLIATIVE CARE IN ESLD

KYLE P. EDMONDS, MD

[email protected]

858-534-7079


Recommended